CEO Buys 154k Shares of Treace Medical Concepts, Betting on FDA‑Approval Surge
CEO buys 154k shares of Treace Medical Concepts (TMCO), signaling confidence ahead of FDA approval for its 3‑D bunion‑correction system—could boost a $148 M small‑cap stock.
5 minutes to read

